Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+ T-cells.

Křížová L, Kuchař M, Petroková H, Osička R, Hlavničková M, Pelák O, Černý J, Kalina T, Malý P.

Autoimmunity. 2017 Mar;50(2):102-113. doi: 10.1080/08916934.2016.1272598. Epub 2017 Jan 19.

PMID:
28100093
2.

Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients.

Guggino G, Ciccia F, Di Liberto D, Lo Pizzo M, Ruscitti P, Cipriani P, Ferrante A, Sireci G, Dieli F, Fourniè JJ, Giacomelli R, Triolo G.

Clin Exp Immunol. 2016 Dec;186(3):277-283. doi: 10.1111/cei.12853. Epub 2016 Oct 21.

3.

Transcriptional network profile on synovial fluid T cells in psoriatic arthritis.

Fiocco U, Martini V, Accordi B, Caso F, Costa L, Oliviero F, Scanu A, Facco M, Boso D, Gatto M, Felicetti M, Frallonardo P, Ramonda R, Piva L, Zambello R, Agostini C, Scarpa R, Basso G, Semenzato G, Dayer JM, Punzi L, Doria A.

Clin Rheumatol. 2015 Sep;34(9):1571-80. doi: 10.1007/s10067-015-3002-2. Epub 2015 Jul 9.

PMID:
26152611
4.

Genetics of psoriatic arthritis.

O'Rielly DD, Rahman P.

Best Pract Res Clin Rheumatol. 2014 Oct;28(5):673-85. doi: 10.1016/j.berh.2014.10.010. Epub 2014 Nov 22. Review.

PMID:
25488777
5.

IL-23R gene polymorphism rs2201841 is associated with psoriatic arthritis.

Popadic S, Ramic Z, Medenica Lj, Pravica V, Popadic D.

Int J Immunogenet. 2014 Aug;41(4):335-7. doi: 10.1111/iji.12127. Epub 2014 Jun 9.

PMID:
24910145
6.

JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis.

Fiocco U, Accordi B, Martini V, Oliviero F, Facco M, Cabrelle A, Piva L, Molena B, Caso F, Costa L, Scanu A, Pagnin E, Atteno M, Scarpa R, Basso G, Semenzato G, Punzi L, Doria A, Dayer JM.

Immunol Res. 2014 Jan;58(1):61-9. doi: 10.1007/s12026-013-8481-0.

PMID:
24385089
7.

Th17 and Th22 cells in psoriatic arthritis and psoriasis.

Benham H, Norris P, Goodall J, Wechalekar MD, FitzGerald O, Szentpetery A, Smith M, Thomas R, Gaston H.

Arthritis Res Ther. 2013 Sep 26;15(5):R136. doi: 10.1186/ar4317.

8.

Axial spondyloarthritis: thoughts about nomenclature and treatment targets.

Braun J.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S132-5. Epub 2012 Oct 18.

PMID:
23079005
9.

IL-23A, IL-23R, IL-17A and IL-17R polymorphisms in different psoriatic arthritis clinical manifestations in the northern Italian population.

Catanoso MG, Boiardi L, Macchioni P, Garagnani P, Sazzini M, De Fanti S, Farnetti E, Casali B, Chiarolanza I, Nicoli D, Luiselli D, Salvarani C.

Rheumatol Int. 2013 May;33(5):1165-76. doi: 10.1007/s00296-012-2501-6. Epub 2012 Sep 7.

PMID:
22955875
10.

Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis.

Kenna TJ, Davidson SI, Duan R, Bradbury LA, McFarlane J, Smith M, Weedon H, Street S, Thomas R, Thomas GP, Brown MA.

Arthritis Rheum. 2012 May;64(5):1420-9. doi: 10.1002/art.33507.

11.

Genetic screening test for psoriatic arthritis and UVB irradiation potential responders: A new tool to identify psoriasis subpopulation patients?

Lotti T, Tognetti L, Galeone M, Bruscino N, Moretti S, Giorgini S.

Indian Dermatol Online J. 2011 Jul;2(2):57-63. doi: 10.4103/2229-5178.85991.

12.

Interleukin-23: a key cytokine in inflammatory diseases.

Duvallet E, Semerano L, Assier E, Falgarone G, Boissier MC.

Ann Med. 2011 Nov;43(7):503-11. doi: 10.3109/07853890.2011.577093. Epub 2011 May 17. Review.

PMID:
21585245
13.

The genetic basis of spondyloarthritis.

Reveille JD.

Ann Rheum Dis. 2011 Mar;70 Suppl 1:i44-50. doi: 10.1136/ard.2010.140574. Review.

PMID:
21339218
14.

Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.

Puwipirom H, Hirankarn N, Sodsai P, Avihingsanon Y, Wongpiyabovorn J, Palaga T.

Arthritis Res Ther. 2010;12(6):R215. doi: 10.1186/ar3194. Epub 2010 Nov 29.

15.

Where do we stand with the genetics of psoriatic arthritis?

O'Rielly DD, Rahman P.

Curr Rheumatol Rep. 2010 Aug;12(4):300-8. doi: 10.1007/s11926-010-0111-4. Review.

PMID:
20480402
16.

Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis.

Schonthaler HB, Huggenberger R, Wculek SK, Detmar M, Wagner EF.

Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21264-9. doi: 10.1073/pnas.0907550106. Epub 2009 Dec 7.

17.

Therapy of spondyloarthritides.

Braun J.

Adv Exp Med Biol. 2009;649:133-47. Review.

PMID:
19731626
18.

Association of interleukin 23 receptor variants with psoriatic arthritis.

Rahman P, Inman RD, Maksymowych WP, Reeve JP, Peddle L, Gladman DD.

J Rheumatol. 2009 Jan;36(1):137-40. doi: 10.3899/jrheum.080458.

PMID:
19040306
19.

Investigation of association of the IL12B and IL23R genes with psoriatic arthritis.

Filer C, Ho P, Smith RL, Griffiths C, Young HS, Worthington J, Bruce IN, Barton A.

Arthritis Rheum. 2008 Dec;58(12):3705-9. doi: 10.1002/art.24128. Erratum in: Arthritis Rheum. 2012 Apr;64(4):1302.

20.

Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis.

Hüffmeier U, Lascorz J, Böhm B, Lohmann J, Wendler J, Mössner R, Reich K, Traupe H, Kurrat W, Burkhardt H, Reis A.

J Invest Dermatol. 2009 Feb;129(2):355-8. doi: 10.1038/jid.2008.233. Epub 2008 Sep 18.

Supplemental Content

Loading ...
Support Center